This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Covetrus Future Growth

Future criteria checks 0/6

Key information

n/a

Earnings growth rate

54.7%

EPS growth rate

Healthcare earnings growth18.9%
Revenue growth rate5.6%
Future return on equity10.6%
Analyst coverage

Low

Last updatedn/a

Recent future growth updates

Recent updates

Covetrus GAAP EPS of -$0.03 misses by $0.06, revenue of $1.22B in-line

Aug 04

Clayton, Dubilier & Rice/TPG Are Not Offering Fair Value To Covetrus Shareholders

Jun 02

Covetrus, Inc.'s (NASDAQ:CVET) Intrinsic Value Is Potentially 98% Above Its Share Price

May 02
Covetrus, Inc.'s (NASDAQ:CVET) Intrinsic Value Is Potentially 98% Above Its Share Price

Are Investors Undervaluing Covetrus, Inc. (NASDAQ:CVET) By 40%?

Jan 07
Are Investors Undervaluing Covetrus, Inc. (NASDAQ:CVET) By 40%?

We Think Covetrus (NASDAQ:CVET) Has A Fair Chunk Of Debt

Oct 21
We Think Covetrus (NASDAQ:CVET) Has A Fair Chunk Of Debt

An Intrinsic Calculation For Covetrus, Inc. (NASDAQ:CVET) Suggests It's 37% Undervalued

Sep 16
An Intrinsic Calculation For Covetrus, Inc. (NASDAQ:CVET) Suggests It's 37% Undervalued

Estimating The Intrinsic Value Of Covetrus, Inc. (NASDAQ:CVET)

May 31
Estimating The Intrinsic Value Of Covetrus, Inc. (NASDAQ:CVET)

Covetrus, Inc. 2021 Q1 - Results - Earnings Call Presentation

May 07

Is Covetrus (NASDAQ:CVET) Using Too Much Debt?

May 05
Is Covetrus (NASDAQ:CVET) Using Too Much Debt?

Covetrus, Inc.: Well Positioned To Enjoy Market Crosscurrents

Apr 30

Who Has Been Selling Covetrus, Inc. (NASDAQ:CVET) Shares?

Feb 26
Who Has Been Selling Covetrus, Inc. (NASDAQ:CVET) Shares?

We Think Covetrus (NASDAQ:CVET) Has A Fair Chunk Of Debt

Jan 22
We Think Covetrus (NASDAQ:CVET) Has A Fair Chunk Of Debt

Covetrus reports Q4 net sales of prescription management business

Jan 13

Covetrus (NASDAQ:CVET) Shareholders Have Enjoyed An Impressive 106% Share Price Gain

Dec 18
Covetrus (NASDAQ:CVET) Shareholders Have Enjoyed An Impressive 106% Share Price Gain

Covetrus, Inc. 2020 Q3 - Results - Earnings Call Presentation

Nov 12

Covetrus Q3 2020 Earnings Preview

Nov 09

Earnings and Revenue Growth Forecasts

NasdaqGM:CVET - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20245,341N/A125N/A2
12/31/20235,065N/A92N/A4
12/31/20224,789N/A112N/A4
6/30/20224,649-13260N/A
3/31/20224,621-4070126N/A
12/31/20214,575-5442102N/A
9/30/20214,575-5644104N/A
6/30/20214,539-90-602N/A
3/31/20214,376-131072N/A
12/31/20204,339-26-553N/A
9/30/20204,225-193180N/A
6/30/20204,117-940112154N/A
3/31/20204,100-9961858N/A
12/31/20193,976-98064103N/A
9/30/20193,871-94893130N/A
6/30/20193,7762783113N/A
3/31/20193,77265131157N/A
12/29/20183,778101136158N/A
9/30/20183,791697494N/A
6/30/20183,77674103127N/A
3/31/20183,649674264N/A
12/30/20173,5806487108N/A
12/31/20163,3537092105N/A
12/26/20152,97860N/A96N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if CVET's forecast earnings growth is above the savings rate (2%).

Earnings vs Market: Insufficient data to determine if CVET's earnings are forecast to grow faster than the US market

High Growth Earnings: Insufficient data to determine if CVET's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: CVET's revenue (5.6% per year) is forecast to grow slower than the US market (7.3% per year).

High Growth Revenue: CVET's revenue (5.6% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: CVET's Return on Equity is forecast to be low in 3 years time (10.6%).


Discover growth companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2022/10/16 09:03
End of Day Share Price 2022/10/12 00:00
Earnings2022/06/30
Annual Earnings2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Covetrus, Inc. is covered by 10 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullArgus Research Company
Robert EichCleveland Research Company
Erin Wilson WrightCredit Suisse